Summary
DexCom, Inc. (DXCM) filed an 8-K on February 4, 2016, reporting two material events that occurred on February 1, 2016. The company entered into a significant sublease agreement for approximately 132,600 square feet of facility space in San Diego, California, with a lease term extending through January 2022. This expansion in physical footprint suggests anticipated growth and operational scaling. The total rent obligation over the lease term amounts to $14.6 million, exclusive of real estate taxes and operating costs. Additionally, DexCom amended and restated its distribution agreement with Byram Healthcare. This amendment extends the non-exclusive distribution of DexCom's G5 Mobile continuous glucose monitoring system and consolidates previous changes. Byram represented approximately 18% of DexCom's total revenue for the twelve months ended December 31, 2015, highlighting the importance of this continued partnership for the company's sales performance.
Key Highlights
- 1DexCom signed a sublease agreement for 132,600 square feet of facility space in San Diego, California.
- 2The new facility lease term extends through January 2022.
- 3Total rent obligation for the sublease is $14.6 million over the lease term (excluding taxes and operating costs).
- 4DexCom entered into an Amended and Restated Distribution Agreement with Byram Healthcare.
- 5The agreement extends Byram's non-exclusive distribution of DexCom's G5 Mobile continuous glucose monitoring system.
- 6Byram accounted for approximately 18% of DexCom's revenue in the twelve months ended December 31, 2015.
- 7The filing indicates potential company growth and operational expansion through the new facility.